326 related articles for article (PubMed ID: 23344057)
1. RUNX1: A microRNA hub in normal and malignant hematopoiesis.
Rossetti S; Sacchi N
Int J Mol Sci; 2013 Jan; 14(1):1566-88. PubMed ID: 23344057
[TBL] [Abstract][Full Text] [Related]
2. A role for RUNX1 in hematopoiesis and myeloid leukemia.
Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
[TBL] [Abstract][Full Text] [Related]
3. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
4. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
5. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells.
Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS
Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288
[TBL] [Abstract][Full Text] [Related]
6. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
7. A 5' untranslated region containing the IRES element in the Runx1 gene is required for angiogenesis, hematopoiesis and leukemogenesis in a knock-in mouse model.
Nagamachi A; Htun PW; Ma F; Miyazaki K; Yamasaki N; Kanno M; Inaba T; Honda Z; Okuda T; Oda H; Tsuji K; Honda H
Dev Biol; 2010 Sep; 345(2):226-36. PubMed ID: 20647008
[TBL] [Abstract][Full Text] [Related]
8. The RUNX1-PU.1 axis in the control of hematopoiesis.
Imperato MR; Cauchy P; Obier N; Bonifer C
Int J Hematol; 2015 Apr; 101(4):319-29. PubMed ID: 25749719
[TBL] [Abstract][Full Text] [Related]
9. Ectopic Runx1 expression rescues Tal-1-deficiency in the generation of primitive and definitive hematopoiesis.
Tornack J; Seiler K; Grützkau A; Grün JR; Onodera M; Melchers F; Tsuneto M
PLoS One; 2013; 8(7):e70116. PubMed ID: 23922928
[TBL] [Abstract][Full Text] [Related]
10. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
[TBL] [Abstract][Full Text] [Related]
11. AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis.
Kurokawa M
Int J Hematol; 2006 Aug; 84(2):136-42. PubMed ID: 16926135
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell emergence in the conceptus and the role of Runx1.
Swiers G; de Bruijn M; Speck NA
Int J Dev Biol; 2010; 54(6-7):1151-63. PubMed ID: 20711992
[TBL] [Abstract][Full Text] [Related]
13. Alternative RUNX1 Promoter Regulation by Wnt/β-Catenin Signaling in Leukemia Cells and Human Hematopoietic Progenitors.
Medina MA; Ugarte GD; Vargas MF; Avila ME; Necuñir D; Elorza AA; Gutiérrez SE; De Ferrari GV
J Cell Physiol; 2016 Jul; 231(7):1460-7. PubMed ID: 26580584
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
15. [Epigenetic mechanism of RUNX1 in pathogenesis of leukemia].
Zhang H; Zheng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):525-30. PubMed ID: 20416203
[TBL] [Abstract][Full Text] [Related]
16. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
Sroczynska P; Lancrin C; Kouskoff V; Lacaud G
Blood; 2009 Dec; 114(26):5279-89. PubMed ID: 19858498
[TBL] [Abstract][Full Text] [Related]
17. Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.
Yokomizo T; Yanagida M; Huang G; Osato M; Honda C; Ema M; Takahashi S; Yamamoto M; Ito Y
Int J Hematol; 2008 Sep; 88(2):134-138. PubMed ID: 18594778
[TBL] [Abstract][Full Text] [Related]
18. The role of Runx1/AML1 and Evi-1 in the regulation of hematopoietic stem cells.
Kumano K; Kurokawa M
J Cell Physiol; 2010 Feb; 222(2):282-5. PubMed ID: 19847803
[TBL] [Abstract][Full Text] [Related]
19. Runx1/AML1 in leukemia: disrupted association with diverse protein partners.
Perry C; Eldor A; Soreq H
Leuk Res; 2002 Mar; 26(3):221-8. PubMed ID: 11792409
[TBL] [Abstract][Full Text] [Related]
20. Runx1/AML1 in normal and abnormal hematopoiesis.
Yamagata T; Maki K; Mitani K
Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]